Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Thoracic Cancer is Scopus-indexed (Q2, CiteScore 5.2), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1759-7706Verify ISSN ↗1759-7714Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 46 / 165 | 72nd | Q2 |
| Oncology | 148 / 428 | 65th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 5.2.
Thoracic Cancer is Q2 in Pulmonary and Respiratory Medicine (rank 46 of 165) and Q2 in Oncology (rank 148 of 428), by CiteScore 2025.
Thoracic Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.2, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.779, quartile Q2, with an H-index of 60.
The publisher lists an article processing charge of about US$3,030 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Thoracic Cancer is published by John Wiley and Sons Inc. Its print ISSN is 1759-7706 and its online ISSN is 1759-7714.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Thoracic Cancer has an h-index of 70 and a 2-year mean of 2.3 citations per paper (OpenAlex). Its Scopus CiteScore is 5.2, quartile Q2. On 2-year citations it ranks #52 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Thoracic Cancer published 279 papers in 2025; its busiest recent year was 2021 with 519. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (47.6%), Japan (20.3%) and South Korea (10.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 18 retracted papers are recorded (4.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.